FDA Seeks Advisory Role In Facilitating Critical Path Research
Executive Summary
FDA expects to play the role of a "neutral referee" to facilitate external research conducted under the agency's Critical Path initiative
You may also be interested in...
FDA Risk Communication Research May Follow Critical Path To Avoid OMB
FDA may need to undertake an approach similar to the agency's Critical Path initiative in order to facilitate research evaluating its communication efforts
FDA Risk Communication Research May Follow Critical Path To Avoid OMB
FDA may need to undertake an approach similar to the agency's Critical Path initiative in order to facilitate research evaluating its communication efforts
Critical Path Consortium To Allow Patents But Preserve Access For Partners
The Predictive Safety Testing Consortium will allow companies to patent safety testing methodologies developed through the collaboration, but firms will be required to grant access to other members